- Barrons.com
Eli Lilly’s Weight-Loss Franchise Has Been a Massive Winner Under Dave Ricks
Zepbound and related products could generate more than $50 billion of sales in 2029. There is a lot more in Lilly’s pipeline.
- Zacks
Here's How Much a $1000 Investment in Eli Lilly Made 10 Years Ago Would Be Worth Today
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
- Zacks
The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly
Pfizer, Johnson & Johnson and Eli Lilly are part of the Zacks top Analyst Blog.
